In accordance with its role in sustaining MS progression, recent reports indicate that astroglia-specific Cx43 ablation attenuates EAE clinical signs, with reduced F4/80+ macrophages and CD45+ cells infiltration (Une et al., 2021). Here, GJA1 is linked to myeloid sarcoma.